Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 5
Submit an article Journal homepage
430
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy

Thomas E. LewFaculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia;
,
Chan Y. CheahDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia; ;University of Melbourne, Parkville, Australia;
,
Dennis A. CarneyDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia; ;University of Melbourne, Parkville, Australia;
,
H. Miles PrinceDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia; ;University of Melbourne, Parkville, Australia;
,
Max WolfDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia; ;University of Melbourne, Parkville, Australia;
,
Ali BazarganDepartment of Hematology, St Vincent’s Hospital, Fitzroy, Australia
,
E. Henry JanuszewiczDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia;
,
Robin FilshieDepartment of Hematology, St Vincent’s Hospital, Fitzroy, Australia
,
David WestermanDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia;
,
John F. SeymourDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia; ;University of Melbourne, Parkville, Australia;
&
Constantine S. TamDepartment of Hematology, Peter MacCallum Cancer Centre, East Melbourne, Australia; ;University of Melbourne, Parkville, Australia; Correspondence[email protected]
 show all
Pages 1044-1053 | Received 27 May 2015, Accepted 14 Sep 2015, Published online: 20 Nov 2015

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Francesca R. Mauro, Adriano Salaroli, Maria D. Caputo, Gioia Colafigli, Luigi Petrucci, Melissa Campanelli, Antonietta Ferretti, Anna R Guarini & Robin Foà. (2016) Management of elderly and unfit patients with chronic lymphocytic leukemia. Expert Review of Hematology 9:12, pages 1165-1175.
Read now
Paula Cramer, Petra Langerbeins, Kirsten Fischer, Barbara Eichhorst, Michael Hallek & Valentin Goede. (2016) Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all?. Leukemia & Lymphoma 57:5, pages 987-990.
Read now

Articles from other publishers (3)

Yang Han, Xinting Hu, Xiaoya Yun, Jiarui Liu, Juan Yang, Zheng Tian, Xin Zhang, Ya Zhang & Xin Wang. (2021) Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. Cell Death & Disease 12:11.
Crossref
C. Buske, M. Hutchings, M. Ladetto, V. Goede, U. Mey, P. Soubeyran, M. Spina, R. Stauder, M. Trněný, U. Wedding, P. Fields, Christian Buske, Martin Dreyling, Andrés J M Ferreri, Paul Fields, Gianluca Gaidano, Valentin Goede, Martin Hutchings, Marco Ladetto, Steven Le Gouill, Stefano Luminari, Ulrich Mey, Peter de Nully Brown, Michael Pfreundschuh, Christiane Pott, Norbert Schmitz, Pierre Soubeyran, Michele Spina, Reinhard Stauder, Anna Sureda Balari, Marek Trněný, Gustaaf van Imhoff, Jan Walewski, Ulrich Wedding, Alberto Zamò & Emanuele Zucca. (2018) ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma. Annals of Oncology 29:3, pages 544-562.
Crossref
. (2016) Cyclophosphamide/fludarabine/rituximab. Reactions Weekly 1612:1, pages 69-69.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.